Exploration of the pharmacophore of 3-alkyl-5-arylimidazolidinediones as new CB1 cannabinoid receptor ligands and potential antagonists: Synthesis, lipophilicity, affinity, and molecular modeling

Frédéric Ooms, Johan Wouters, Olivier Oscari, Thierry Happaerts, Géraldine Bouchard, Pierre Alain Carrupt, Bernard Testa, Didier M. Lambert

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Exploration of the pharmacophore of 3-alkyl-5-arylimidazolidinediones as new CB1 cannabinoid receptor ligands and potential antagonists: Synthesis, lipophilicity, affinity, and molecular modeling'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science